The two 90-minute sessions, led by clinical psychologist Dr Helena Tucker, will cover how menstrual hormones affect stress, performance and emotional regulation, what realistic workplace adjustments can look like, how to advocate for yourself and others and how to engage colleagues and leadership in creating sustainable, stigma-free change.
They will also look at the workplace impact of PMS, PMDD, perimenopause, menopause, fertility challenges, pregnancy loss, hormonal treatment and other “significant hormonal transitions”.
The organisers said the content is designed to be “realistic about the demands of veterinary environments” and aimed at individuals and leaders having meaningful conversations about support and adjustments.
Katie Ford, co-founder of Vet Empowered, said: “You may never personally experience menstrual hormones, but you almost certainly live with someone who does, or have someone in your team who does.
"Understanding our biology as human beings, and how we can thoughtfully adapt our workplaces to honour that, benefits everyone.
"This is not about resilience or weakness.
"It is about biology, and what we can do with that knowledge.”
Session 1, Creating a Hormone-Friendly Veterinary Workplace, runs on Sunday 29 March 2026 at 10:00am BST for 90 minutes.
Session 2, From Awareness to Action - Advocacy and Sustainable Support in Veterinary Teams, runs on Saturday 11 April 2026 at 10:00am BST for 90 minutes.
The organisers said both sessions will be recorded and are open to vets, nurses, practice managers, leaders, and anyone who wants to better support colleagues and teams.
https://us02web.zoom.us/meeting/register/1gjSl4osQkKnihbgUVRpQQ#/registration
Henry Schein said in a statement on Friday that it had sold the business in order to focus on its dental and medical markets and pursue new investment opportunities.
Covetrus says it will be using the experience, technology and global scale of the merged companies to provide veterinary practices with a more comprehensive set of integrated services and technology solutions, and tools to strengthen client relationships and grow their practice.
Covetrus launched on Nasdaq last Friday, when President and Chief Executive Officer Benjamin Shaw, said: "Today marks an important new chapter in the world of veterinary medicine, as we launch Covetrus as a new company listed on Nasdaq.
"We look forward to strengthening our customer relationships and expanding our veterinary practice partnerships worldwide as we bring more comprehensive and powerful solutions to market to meet their evolving needs and improve health and financial outcomes."